These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6182427)

  • 1. Abnormalities of axonal transport: are they a cause of peripheral nerve disease?
    Brimijoin WS
    Mayo Clin Proc; 1982 Nov; 57(11):707-14. PubMed ID: 6182427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal transport in neuropathy.
    Jakobsen J; Brimijoin S; Sidenius P
    Muscle Nerve; 1983 Feb; 6(2):164-6. PubMed ID: 6190080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormalities of axonal transport as pathogenesis of axonal degeneration in peripheral neuropathy].
    Nagata H
    Rinsho Shinkeigaku; 1990 Dec; 30(12):1355-7. PubMed ID: 1966015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal transport in the motor neurons of rats with neuropathy induced by p-bromophenylacetylurea.
    Nagata H; Brimijoin S
    Ann Neurol; 1986 May; 19(5):458-64. PubMed ID: 2424360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. I. The effects of single doses of acrylamide on the rate and capacity of transport.
    Sickles DW
    Neurotoxicology; 1989; 10(1):91-101. PubMed ID: 2475836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impairment of rapid axonal transport and concomitant anomaly of smooth endoplasmic reticulum in acrylamide induced neuropathy].
    Chrétien M; Souyri F; Patey G
    C R Seances Acad Sci D; 1979 Feb; 288(7):689-92. PubMed ID: 88279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered spectrum of retrogradely transported axonal proteins in p-bromophenylacetylurea neuropathy.
    Oka N; Brimijoin S
    Neurochem Res; 1993 Jun; 18(6):675-80. PubMed ID: 8389990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal transport of enzymes and labeled proteins in experimental axonopathy induced by p-bromophenylacetylurea.
    Jakobsen J; Brimijoin S
    Brain Res; 1981 Dec; 229(1):103-22. PubMed ID: 6171326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased axonal transport of structural proteins in streptozotocin diabetic rats.
    Jakobsen J; Sidenius P
    J Clin Invest; 1980 Aug; 66(2):292-7. PubMed ID: 6156952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nervous system abnormality and nervous disease in diabetes.
    Jakobsen J; Sidenius P; Lundbaek K
    Acta Endocrinol Suppl (Copenh); 1980; 238():123-31. PubMed ID: 6159763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats.
    Yagihashi S; Kamijo M; Watanabe K
    Am J Pathol; 1990 Jun; 136(6):1365-73. PubMed ID: 2141449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural study of zinc pyridinethione-induced peripheral neuropathy.
    Sahenk Z; Mendell JR
    J Neuropathol Exp Neurol; 1979 Sep; 38(5):532-50. PubMed ID: 224150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology of the peripheral neuropathy induced by p-bromophenylacetylurea.
    Troncoso JC; Griffin JW; Price DL; Hess-Kozlow KM
    Lab Invest; 1982 Feb; 46(2):215-23. PubMed ID: 7062723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effects of acrylamide and experimental diabetes on the retrograde axonal transport of proteins in the rat sciatic nerve: analysis by two-dimensional polyacrylamide gel electrophoresis.
    Logan MJ; McLean WG
    J Neurochem; 1988 Jan; 50(1):183-9. PubMed ID: 2447233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI of peripheral nerve degeneration and regeneration: correlation with electrophysiology and histology.
    Bendszus M; Wessig C; Solymosi L; Reiners K; Koltzenburg M
    Exp Neurol; 2004 Jul; 188(1):171-7. PubMed ID: 15191813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the ability of d-penicillamine to protect rats against the neurotoxicity induced by zinc pyridinethione, acrylamide, 2,5-hexanedione and p-bromophenylacetylurea.
    LoPachin RM; Weiler MS; Williams KD; Peterson RE
    Neurotoxicology; 1984; 5(2):37-41. PubMed ID: 6542189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of alpha-synuclein in the nervous system enhances axonal degeneration after peripheral nerve lesion in a transgenic mouse strain.
    Siebert H; Kahle PJ; Kramer ML; Isik T; Schlüter OM; Schulz-Schaeffer WJ; Brück W
    J Neurochem; 2010 Aug; 114(4):1007-18. PubMed ID: 20524960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular distribution and immunological detection of retrograde axonally transported proteins in acrylamide and diabetic neuropathies.
    Hargreaves AJ; McLean WG
    Neurosci Lett; 1993 Dec; 163(2):201-4. PubMed ID: 7508589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve.
    Lee PG; Hohman TC; Cai F; Regalia J; Helke CJ
    Exp Neurol; 2001 Jul; 170(1):149-61. PubMed ID: 11421592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemia-reperfusion injury of peripheral nerve in experimental diabetic neuropathy.
    Wang Y; Schmelzer JD; Schmeichel A; Iida H; Low PA
    J Neurol Sci; 2004 Dec; 227(1):101-7. PubMed ID: 15546599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.